The Latest Breaking News from Merck

The Dow Jones plunged as the latest Fed meeting kicked off. Carl Icahn hit back after Icahn Enterprises stock got slammed. Uber stock soared.

Industry analysts warn that a groundbreaking change in how Medicare buys drugs threatens industry growth, profits — and maybe patient care.

The long-term prospects of Merck (MRK) look bright due to its latest acquisitions and solid drug pipeline. Therefore, investing in this stock could help generate substantial returns in the long run. Keep reading….

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.33%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.30%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.06%. Stock indexes Monday posted moderate gains. An increase in...

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.05%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.23%. U.S. stock indexes this morning are mixed. An increase...

Moderna stock crumbled Monday after updated results for its Merck-partnered cancer vaccine show a "longish and complex path" toward approval.

Google parent Alphabet sold off more than 3% after Samsung considered ditching the search engine.

Merck is acquiring Prometheus Bio in a well-timed $10.8 billion deal ahead of Keytruda's patent loss. The news sent RXDX stock flying Monday.

Morning Markets June S&P 500 futures (ESM2 3) this morning are up +0.02%, and June Nasdaq 100 E-Mini futures (NQM2 3) are down -0.03%. U.S. stock index futures this morning are mixed. An increase in M&A activity is positive for stocks after Merck said it would acquire Prometheus Biosciences for...